Introduction
Withdrawal of survival factors activates the 'cell intrinsic' apoptotic pathway, resulting in the release of cytochrome c from mitochondria, activation of caspase-9 and consequent activation of 'effector' caspases that drive the execution phase of apoptosis (reviewed by Zamzami et al., 1998; Hengartner, 2000; Martinou and Green, 2001 ). This evolutionarily conserved pathway is regulated by the Bcl-2 proteins (reviewed in Adams and Cory, 2001 ). The prosurvival Bcl-2 proteins, such as Bcl-2 and Bcl-x L , display sequence conservation in all four Bcl-2 homology domains (BH1-4 domains), whereas the proapoptotic Bcl-2 proteins, such as Bax and Bak, lack the N-terminal BH4 domain (Kelekar and Thompson, 1998; Adams and Cory, 2001) . The BH3 domain is an important death-promoting domain, as underlined by the existence of pro-apoptotic 'BH3-only' proteins such as Bad, Bid and Bim (reviewed by Puthalakath and Strasser, 2002) . Pro-death proteins such as Bax and Bak act by promoting the release of cytochrome c from the mitochondria and they are in turn repressed by binding to pro-survival proteins such as Bcl-2 and Bcl-x L (Adams and Cory, 2001; Martinou and Green, 2001 ). BH3-only proteins respond to a variety of stresses by binding to Bcl-2 and Bcl-x L , resulting in conformational changes in Bax and Bak (Makin et al., 2001) , which then promote cell death. In addition, some BH3-only proteins may also interact directly with Bax to promote cell death (Marani et al., 2002) . Certainly, Bax and Bak are required for BH3-only proteins to promote cell death (Wei et al., 2001) .
BH3-only proteins act as 'sentinels of stress' and are subject to many forms of regulation. Bid is activated by caspase-8-dependent cleavage to yield tBid (Li et al., 1998) . Bad is phosphorylated by PKB, thereby promoting binding to 14-3-3, which blocks interactions with Bcl-2 (Zha et al., 1996; Datta et al., 2000) . This may be one mechanism for the prosurvival effects of the PI3K-PDK-PKB pathway (reviewed by Downward, 1998; Talapatra and Thompson, 2001 ). In addition, some BH3-only genes are expressed de novo in response to death signals; for example, Noxa (Oda et al., 2000) and Puma (Nakano and Vousden, 2001; Yu et al., 2001) are transcriptionally upregulated by p53 in response to DNA damage, while Hrk/DP5 is upregulated by NGF withdrawal (Imaizumi et al., 1997 (Imaizumi et al., , 1999 .
The BH3-only gene Bim/BOD (Hsu et al., 1998; O'Connor et al., 1998) is expressed de novo following withdrawal of survival factors. Bim proteins are detected at low levels in a variety of tissues and cell types (O'Reilly et al., 2000) but, to date, their regulated expression has only been demonstrated in two cell types.
In certain haematopoietic cell lines withdrawal of cytokines results in loss of PI3K activity, dephosphorylation and nuclear entry of the forkhead transcription factor FKHR-L1/FOXO-3A (Brunet et al., 1999) and increased expression of Bim (Dijkers et al., 2000) . In primary sympathetic neurons, Bim expression in response to withdrawal of NGF requires both the stressactivated protein kinase JNK, and its target c-Jun (Putcha et al., 2001; Whitfield et al., 2001) .
The ability to survive and grow at reduced growth factor concentrations is a property shared by many tumour cells. Mutational activation of Ras can protect cells from some apoptotic insults, including serum withdrawal (Downward, 1998) . In addition to the wellknown prosurvival effects of PI3K-PDK-PKB pathway, studies in a variety of cells have shown that the Raf-MEK-ERK pathway can also promote survival in the face of factor withdrawal and other stresses; these effects are frequently independent of the PI3K pathway (Kinoshita et al., 1997; Erhardt et al., 1999; LeGall et al., 2000; reviewed in Baliff and Blenis, 2001) . Indeed, knockout of c-Raf-1 (Mikula et al., 2001; Huser et al., 2001) or B-Raf (Wojnowski et al., 1997) results in embryonic lethality characterized by enhanced apoptosis in discrete tissues, suggesting that delivery of cell survival signals is a major function of the Raf-MEK-ERK pathway in vivo.
To investigate the antiapoptotic effect of the ERK pathway, we have focused on the response of CC139 cells to serum withdrawal, a model system in which the ERK pathway exerts a protective effect independently of PI3K (Le Gall et al., 2000) . Here we show that serum withdrawal-induced death is almost completely dependent upon the new gene expression and that Bim EL expression is an early event in this process. Using conditional protein kinases to activate selectively the JNK or ERK pathway we show that the expression of Bim EL occurs independently of the JNK-c-Jun pathway and is inhibited by the Raf-MEK-ERK pathway independently of the PI3K pathway.
Results

New gene expression is required for serum withdrawalinduced activation of Bax and caspase-dependent apoptosis
Following withdrawal of serum from cycling CC139 cells, we observed the rapid dephosphorylation of ERK1/2 within 1 h and PKB after 3 h, monitored with phospho-specific antibodies; the total levels of these enzymes remained unchanged throughout the time course (Figure 1a) . Activation of caspases, as assessed by DEVDase activity in whole cell extracts, was apparent 6 h after removal of serum, peaked at 12 h and then declined back towards basal (Figure 1b ). This was followed by an increase in the percentage of annexin Figure 1 Serum withdrawal induces caspase-dependent apoptosis in CC139 cells. Cycling CC139 cells maintained in 10% FBS were switched to serum-free medium or fresh medium containing 10% FBS for the indicated time points and then assayed for (a) ERK and PKB phosphorylation, (b) DEVDase activity or (c) annexin V staining. (d) Cycling CC139 cells maintained in 10% FBS were switched to serum-free medium or fresh medium containing 10% FBS for 24 h in the presence of 100 mm zVAD.fmk or a vehicle control, and assayed for cell surface annexin V staining. DEVDase activity is expressed as relative fluorescent units (FU) from samples normalized for total cell protein content. Results are mean7s.d. from a single experiment representative of three giving similar results (c, d) or are pooled from six independent experiments (b). The asterisk* in (d) indicates statistically significant from corresponding control value by students 't' test, Po0.05 V-positive cells ( Figure 1c ) and those with sub-G 1 or hypo-diploid DNA (data not shown). The appearance of annexin V-positive cells was strongly inhibited by the broad specificity caspase inhibitor zVAD.fmk (Figure 1d ), indicating that this is a caspase-dependent cell death response.
A striking feature of this apoptotic response was its almost complete dependence upon de novo gene expression. Actinomycin D caused a dose-dependent inhibition of serum withdrawal-induced DEVDase activity (Figure 2a) , which was maximal (88% inhibition) at 1 mg/ml actinomycin D. Similarly, cycloheximide caused a 9173% inhibition of DEVDase activity after 12 h of serum withdrawal (significant by t-test, P ¼ 0.007) (Figure 2b ). Both inhibitors also blocked the appearance of annexin V-positive cells (data not shown).
Activation of Bax and/or Bak is required to initiate the cell intrinsic death pathway (Wei et al., 2001 ) and can be monitored by discrete conformational changes that precede their oligomerization and translocation to mitochondria. To monitor this, we used the N-20 antibody that only recognizes the activated conformation of Bax (Makin et al., 2001; Marani et al., 2002) . Cells were lysed in CHAPS buffer to preserve the conformation of Bax, while a further dish of untreated cells was lysed in a 1% Triton X-100 buffer that is sufficient to expose the N-20 epitope. All samples were immunoprecipitated with the N-20 antibody, resolved by standard denaturing SDS-PAGE and then blotted for the presence of Bax (Figure 2c ). Controls cells exhibited little conformationally active Bax, whereas etoposide treatment caused a moderate increase, and cells lysed in Triton X-100 exhibited a substantial exposure of the N-20 Bax epitope. Exposure of the Bax N-20 epitope was also clearly observed in response to serum withdrawal and this response was strongly inhibited by cycloheximide (Figure 2c ). The total level of Bax in whole cell lysates did not change indicating that CHX treatment was not exerting a protective effect by simply reducing Bax expression. Thus, following serum withdrawal the early steps of Bax activation and the subsequent apoptotic signalling cascade are almost completely dependent upon the de novo expression of death-promoting genes.
Serum withdrawal induces the de novo expression of Bim
Four of the BH3-only genes described to date are transcriptionally upregulated in response to stress. However, Noxa and PUMA are expressed in response to DNA damage (Oda et al., 2000; Nakano and Vousden, 2001; Yu et al., 2001) and Hrk/DP5 is only expressed in neuronal tissue (Imaizumi et al., 1997) . In contrast, Bim is widely expressed, so we examined the expression of Bim in response to serum withdrawal in CC139 cells.
Three splice variants of Bim, encoding the proteins Bim S , Bim L and Bim EL , were originally described (O'Connor et al., 1998 increased as early as 2 h and was sustained for at least 20 h (Figure 3a) . The appearance of Bim EL occurred soon after the dephosphorylation of ERK but preceded the activation of caspases (Figure 1 ). We also detected increases in Bim L following overexposure of the blot, indicating that Bim L is expressed at much lower levels (see Figure 3a , second panel from top). To date, we have only been able to detect Bim S by transient over expression in HEK293 cells (data not shown). Over the same time course we observed a slight decrease in the level of Bcl-2 and Bcl-x L but only at later times ( Figure 3a) . Thus, the increase in Bim EL expression and consequent increase in the ratio of Bim/Bcl-2 or Bim/Bcl-x L was an early event following serum withdrawal and prior to caspase activation. Increased expression of Bim EL was observed when serum was reduced to 1% (v/v) and the response was essentially maximal at 0.1% (v/v) . Over this range the phosphorylation of ERK1/2 exhibited a reciprocal relationship to Bim EL expression (data not shown). Thus, the expression of Bim EL is intimately linked to the presence of serum growth factors.
When CC139 cells were pretreated for 30 min with cycloheximide or actinomycin D and then switched to serum-free medium containing these inhibitors for 5 h, the increase in expression of Bim EL was completely blocked (Figure 3b ) suggesting that the response to serum removal requires the de novo transcription of Bim mRNA and synthesis of new Bim EL protein.
To determine whether increased expression of Bim was sufficient to promote apoptosis in these cells, CC139 cells were transiently transfected with either EGFP or EGFP-Bim EL by electroporation. This construct drives the expression of Bim EL but, despite an intact splice donor site, only smaller amounts of Bim L and Bim S (data not shown). EGFP-positive cells were sorted by FACS, fixed and stained with propidium iodide to assess the percentage of cells with hypo-diploid DNA ( Figure 3c ). Expression of EGFP-Bim EL caused a striking increase in apoptotic cells (82% compared with 26% for EGFP alone), indicating that Bim EL can induce apoptosis in CC139 cells. Expression of Bim EL also inhibited colony formation in clonogenicity assays (data not shown).
The fact that serum withdrawal-induced death and Bim EL expression both required new mRNA and protein synthesis, together with the rapid expression of Bim and its ability to kill CC139 cells when transiently expressed strongly suggests that Bim is likely to be a regulator of serum withdrawal-induced cell death in these cells.
The JNK-c-Jun pathway is not required for Bim expression in response to serum deprivation
The JNK-c-Jun pathway is required for the expression of Bim and cell death following withdrawal of NGF in sympathetic neurons and PC12 cells (Estus et al., 1994; Ham et al., 1995; Putcha et al., 2001; Whitfield et al., 2001) . To assess if the JNK-c-Jun pathway was Figure 3 Serum withdrawal-induced Bim expression is an early event and requires new RNA and protein synthesis. (a) CC139 cells maintained in 10% FBS were switched to serum-free medium for the times indicated. Whole cell lysates were fractionated by SDS-PAGE and immunoblotted with antibodies for Bim, Bcl-x L and Bcl-2. In the case of Bim the upper blot was overexposed to reveal the low level of Bim L in comparison with Bim EL (second blot from the top). (b) CC139 cells were maintained in 10% FBS or switched to serum-free medium containing 10 mg/ml cycloheximide (CHX) or 1 mg/ml actinomycin D (Act-D) for 5 h. Whole cell lysates were fractionated and immunoblotted for Bim EL expression. The arrow -indicates a nonspecific band running above Bim EL that was detected in most experiments and serves as a useful loading control. (c) CC139 cells were electroporated with pEGFP or pEGFP-Bim EL and replated in a medium containing 10% FBS. After 24 h, cells were harvested, sorted into EGFP-positive populations, stained with propidium iodide and their cell cycle distribution assessed by flow cytometry. Data are taken from a single experiment; identical results were obtained in a separate experiment required for the expression of Bim EL in fibroblasts, we utilized three complementary strategies. First, we determined if the JNK pathway was activated upon serum withdrawal. Cycling CC139 cells were either subjected to serum withdrawal or treated with cellular stresses that are known to activate the JNK pathway. When cell extracts were assayed for JNK1 activity, we observed a sustained and robust activation in response to sodium arsenite (NaAs, eightfold) and methyl methane sulphonate (MMS, fivefold), whereas cells subjected to serum withdrawal failed to exhibit activation of JNK1 (data not shown). These results were reflected in c-Jun phosphorylation monitored using both a phospho-serine63-specific antibody and a total c-Jun antibody. Both NaAs and MMS caused a strong increase in c-Jun phosphorylation whereas serum withdrawal caused no detectable increase in c-Jun phosphorylation ( Figure 4a ). Analysis of the same samples revealed that none of the chemical stresses caused an increase in Bim EL expression, whereas serum withdrawal was again very effective ( Figure 4a ).
To determine if activation of JNK alone was sufficient to induce Bim expression, we used a conditional kinase consisting of the catalytic domain of MEKK1 fused in frame to the hormone binding domain of the oestrogen receptor (DMEKK1:ER*). Activation of DMEK-K1:ER* results in the activation of the JNK pathway but not ERK or p38 (Figure 4b) , or PKB or the IkB/ NFkB pathway (SA Molton and SJ Cook, unpublished observations). A detailed characterization of this construct expressed in CC139 cells (called CM1 cells) will appear elsewhere (SA Molton, DE Todd and SJ Cook, manuscript in preparation). When CM1 cells were switched to serum-free medium ERK1/2 were dephosphorylated and Bim EL was expressed but there was no phosphorylation of c-Jun (Figure 4c ). In contrast, if CM1 cells were kept in 10% fetal bovine serum (FBS) but stimulated with 4-hydroxytamoxifen (4-HT) to Figure 4 Bim expression does not require JNK activation or c-Jun expression. (a) CC139 cells maintained in 10% FBS were switched to serum-free medium (SF) or treated with NaAs (100 mm) or MMS (1 mM) for 4 or 6 h. Whole cell lysates were subjected to Western blotting with antibodies for Bim, phospho-Ser63-cJun or total c-Jun. (b) CM1 cells (CC139 cells expressing DMEKK1:ER*) maintained in 10% FBS were treated with 100 nm 4-HT or vehicle control for 3 h and whole cell lysates assayed for ERK1, JNK1 or p38a activity. The data represent mean7range of duplicate dishes of cells from a single experiment representative of three. (c) CM1 cells maintained in 10% FBS were either switched to serum-free medium or were maintained in FBS and stimulated with 100 nm 4-HT for the times indicated. Whole cell lysates were subjected to Western blotting with antibodies for Bim, phospho-Ser63-cJun or phospho-ERK1/2. (d) 3T3 cells derived from wild-type (WT) or c-JunÀ/À mice were left untreated (t ¼ 0) or switched to serum-free medium for 12 or 24 h. Whole cell lysates, normalized for protein content, were fractionated by SDS-PAGE and immunoblotted for expression of Bim EL or c-Jun; immunoblotting for total ERK1/2 served as a loading control. The double arrowhead on the c-Jun blot ( ( ) indicates the position of c-Jun-Neo R gene that represents the N-terminal 194 amino acids of c-Jun fused to the neomycin resistance gene and is recognized by the c-Jun (aa 1-79) antibody used here (Hilberg and Wagner, 1992) activate DMEKK1:ER*, we observed a strong increase in c-Jun phosphorylation, but no induction of Bim EL (Figure 4c ). Thus, activation of JNK by DMEKK1:ER* induced c-Jun phosphorylation but failed to induce Bim expression.
Finally, when immortalized 3T3 cell lines derived from wild-type (WT) and c-JunÀ/À mice (Hillberg and Wagner, 1992; Schreiber et al., 1999) were subjected to serum withdrawal, we observed a similar increase in Bim EL in both cell lines (Figure 4d) . Indeed, if anything, slightly higher Bim EL levels were observed in the c-JunÀ/À cells compared to the WT cells. Taken together these results suggest that, in contrast to the situation in primary neurons, the activation of JNK and c-Jun is neither required nor sufficient for serum withdrawal-induced Bim EL expression in fibroblasts.
Inhibition of the MEK-ERK or PI3K pathways induces Bim EL expression in the presence of serum
In the Ba/F3 pro-B cell line the PI3K inhibitor LY294002 or the forkhead transcription factor FOXO-3A are both sufficient to induce Bim expression (Dijkers et al., 2000; Shinjyo et al., 2001) . To determine if the PI3K pathway might be regulating Bim expression, we treated cycling CC139 cells with 20 mm LY294002; serum withdrawal was used as a positive control and the MEK-ERK pathway inhibitor, U0126 (Favata et al., 1998) , was used as a specificity control.
Treatment of cells with LY294002 resulted in an increase in Bim EL expression comparable to that observed in response to serum withdrawal. However, U0126 also induced Bim EL expression to levels similar to that observed in response to serum withdrawal ( Figure 5 ). The specificity of these drugs was confirmed by showing that LY294002 caused dephosphorylation of PKB at all time points but had little effect on phosphorylation of ERK1/2, whereas U0126 caused dephosphorylation of ERK1/2 but did not inhibit PKB phosphorylation. Indeed, U0126 actually caused a reproducible potentiation of PKB phosphorylation. Thus, U0126 was selectively inhibiting the ERK pathway and LY294002 was selectively inhibiting the PI3K pathway. These results suggest that inhibition of either the PI3K or Raf-MEK-ERK pathway, both of which occur upon withdrawal of serum (Figure 1a) , is sufficient to promote Bim expression. Since the role of PI3K in regulating Bim expression has been described previously (Dijkers et al., 2000; Shinjyo et al., 2001) , we focused our attention on the role of the ERK pathway.
DRaf-1:ER* protects CC139 cells from serum withdrawal-induced apoptosis by activating the MEK-ERK pathway but not the PI3K pathway
To study the role of the ERK pathway, we utilized a clone of CC139 cells, CR1-11, expressing DRaf-1:ER*, the conditionally active form of the Raf-1 protein kinase (Woods et al., 1997) . When CR1-11 cells were switched to serum-free medium in the absence or presence of 4-HT, activation of DRaf-1:ER* resulted in the rapid and sustained activation of ERK1 (Figure 6a ), but did not promote activation of JNK1 (Figure 6b ) or p38a (Figure 6c ) even after 24 h of stimulation. Thus, activation of DRaf-1:ER* during serum withdrawal activates ERK without affecting JNK or p38 activity in CC139 cells.
Our choice of CC139 cells for this study was prompted by a recent study suggesting that the ERK pathway can exert a PI3K-independent prosurvival effect in these cells (Le Gall et al., 2000) . By studying caspase activation and annexin V staining we were able to confirm that activation of DRaf-1:ER* during serum withdrawal did indeed result in a pronounced protective effect. For example, activation of DRaf-1:ER* strongly inhibited the appearance of caspase-3-like DEVDase activity and this protective effect was reversed by the MEK-ERK pathway inhibitor, U0126, but not by the PI3K inhibitor, LY294002 (Figure 7a) . Activation of DRaf-1:ER* also prevented the appearance of cells staining positive for annexin V and again the protective effect was reversed by U0126 but not by LY294002 (Figure 7b ). These results confirm that DRaf-1:ER*-induced protection in CC139 cells is mediated via activation of the MEK-ERK pathway and not via the PI3K-PDK-PKB pathway.
In addition, we also examined for the first time the effect of activating DRaf-1:ER* on the serum withdrawal-induced conformational activation of Bax. Withdrawal of serum increased the amount of conformationally active Bax and this was completely reversed by the activation of DRaf-1:ER* (Figure 7c ). In contrast, activation of DRaf-1:ER* had no effect on Figure 5 Selective inhibition of ERK1/2 pathway by U0126 is sufficient to induce Bim EL expression. Cycling CC139 cells maintained in 10% FBS were either switched to serum-free or treated with 20 mm U0126 or 20 mm LY294002 for 6, 12 or 18 h. Following fractionation by SDS-PAGE, whole cell lysates were immunoblotted with antibodies specific for Bim, phospho-ERK1/2, total ERK1/2, phospho-PKB or total PKB. Data are taken from a single experiment representative of three giving similar results the total levels of Bax. Thus, selective activation of the ERK pathway is able to prevent the conformational activation of Bax upstream of the mitochondria as well as downstream markers of cell death.
Activation of the ERK pathway by DRaf-1:ER* inhibits expression of Bim EL following serum withdrawal
Prompted by the cyto-protective effect of DRaf-1:ER*, we examined whether the activation of the ERK pathway had any effect on Bim EL expression. The results of two experiments, representative of six, are shown in Figure 8a and b, and changes in the level of Bim EL protein are quantified in the graph accompanying Figure 8b . We found that the increased expression of Bim EL between 1 and 5 h following withdrawal of serum was strongly inhibited by the activation of DRaf-1:ER* (Figure 8a ). Control blots confrimed that DRaf-1:ER* did not increase PKB phosphorylation, indicating that the repression of Bim EL expression was independent of the PI3K-PDK-PKB pathway. The increase in Bim EL expression was sustained for up to 20 h but started to decline by 30 h (Figure 8b ) by which time cell death was at an advanced stage (Figure 1 ). At all time points, activation of DRaf-1:ER* resulted in a clear reduction in the level of the Bim EL protein. Bim EL levels were typically reduced by 50-60% at 5 h while greater inhibition was apparent at 10 and 20 h. The small increase in Bim L was also reduced upon activation of DRaf-1:ER* (Figure 8b ). In addition, the activation of DRaf-1:ER* induced an apparent reduction in the mobility of Bim EL on SDS-PAGE gels (Figure 8a, b) . This may reflect some form of post-translational modification of the remaining Bim EL protein such as phosphorylation.
The ability of DRaf-1:ER* to block serum withdrawal-induced Bim EL expression was dependent upon the MEK-ERK pathway since it was reversed by U0126, whereas LY294002 had little, if any, effect ( Figure 8c) ; this is consistent with the fact that DRaf-1:ER* activates the ERK pathway but not the PKB pathway (Figure 8a, c) . Furthermore, the ability of DRaf-1:ER* to block Bim EL expression was independent of the JNK-c-Jun pathway since DRaf-1:ER* did not modulate JNK activity (Figure 6b) . Finally, in common with studies in neurons (Putcha et al., 2001) , cell fractionation studies revealed that upon serum withdrawal, newly synthesized Bim EL protein was found in the heavy membrane fraction, containing mitochondrial markers (Figure 8d) . Activation of the ERK pathway by DRaf-1:ER* prevented the expression of Bim and so prevented its accumulation in heavy membrane fractions.
The ERK pathway regulates Bim mRNA levels
Finally, we wished to determine if the ability of the ERK pathway to regulate Bim expression was also seen in other cell lines and was reflected in the changes at the level of the mRNA. For this analysis we used RR1 cells, a Rat-1 cell line expressing DRaf-1:ER* , since the rat Bim/Bod sequence has been published. When RR1 cells were serum starved we again observed an increase in Bim EL protein levels and this was strongly inhibited by the activation of DRaf-1:ER* (Figure 9a ). In addition, when cycling RR1 cells Figure 6 Activation of DRaf-1:ER* during serum withdrawal promotes activation of ERK1 but not JNK1, p38a. CR1-11 cells (CC139 cells expressing DRaf-1ER*) were switched from 10% FBS to serum-free medium for the indicated times in the absence (SF+EtOH control) or presence (SF+4-HT) of 100 nm 4-HT. The activity of endogenous ERK1 (a), JNK1 (b) and p38a (c) was determined by immunocomplex kinase assays. The data are mean7range from duplicate cell dishes and are taken from a single experiment; identical results were obtained in at least two additional experiments were subjected to serum withdrawal or treated with U0126 or LY294002, all three treatments were sufficient to cause a substantial increase in Bim EL and to a lesser extent Bim L (Figure 9b ). These results indicate that the ability of the ERK1/2 pathway to repress Bim expression in CC139 cells is faithfully reproduced in Rat-1 cells. We then used real-time RT-PCR to analyse the levels of Bim transcripts in RR1 cells subjected to serum withdrawal or maintained in 10% FBS and treated with U0126 or LY294002. These samples were prepared in parallel with those in Figure 9b and so are directly comparable. The results of this analysis, normalized to the levels of b-actin, are shown in Figure 9c . Cells subjected to serum withdrawal and those treated with U0126 exhibited a very similar response in which Bim transcripts increased rapidly to peak after 6 h, at which time they were typically elevated by 20-fold (Figure 9c ). These results indicate that serum withdrawal or inhibition of the ERK pathway is sufficient to cause an increase in Bim mRNA. LY294002 caused a slower but greater increase in Bim mRNA that peaked at 12 h and was typically 60-fold over the basal (Figure 9c ). Interestingly, despite the greater increase in Bim mRNA with LY294002 compared to U0126, the magnitude of increase in Bim EL protein was similar for both drugs. In addition to U0126, we also observed increases in Bim mRNA in response to the structurally distinct ERK pathway inhibitor PD184352 (data not shown).
Discussion
Increased expression of Bim EL is a common response to withdrawal of survival factors Withdrawal of serum from CC139 cells resulted in a rapid change in conformation of Bax and subsequent caspase-dependent cell death that required the de novo expression of death-promoting genes; a situation analogous to the classical studies of cell death following withdrawal of NGF from primary sympathetic neurons (Martin et al., 1988) . The BH3-only proteins link discrete cellular stresses to activation of Bax and the core apoptotic machinery. Of the BH3-only proteins reported to date, several observations suggest a role for Bim in serum withdrawal-induced death in CC139 cells. Figure 8 Activation of DRaf-1:ER* inhibits expression of Bim via the MEK-ERK1/2 pathway, but not via JNK or PI3K. (a,b) CR1-11 cells were switched from 10% FBS to serum-free medium for the indicated times in the absence or presence of 100 nm 4-HT to activate DRaf-1:ER* and whole cell lysates were immunoblotted for the presence of Bim, phospho-ERK1/2, total ERK1/2, phospho-PKB and total PKB. In b, the upper panel shows the expression of Bim EL while the lower panel is an overexposure of the upper blot revealing the expression of the shorter form, Bim L . The expression of Bim EL was quantified by scanning densitometry and normalized to the nonspecific band (indicated by the arrow -) which served as a loading control. (c) CR1-11 cells were switched from 10% FBS to serum-free medium for 12 h in the absence or presence of 4-HT to activate DRaf-1:ER* with or without 20 mm U0126 or 20 mm LY294002. Whole cell lysates were immunoblotted for the expression of Bim EL , phospho-ERK1/2 (P-ERK) and total PKB, total ERK, PKB phosphorylated at Ser473 (P-PKB), total PKB and processed caspase-3. (d) CR1-11 cells were switched from 10% FBS to serum-free medium for 12 h in the absence or presence of 4-HT to activate DRaf-1:ER* and in the presence or absence of 20 mm U0126. Cells were then fractionated into cytosolic and heavy membrane fractions and these were immunoblotted for the presence of Bim EL , COX-IV (a mitochondrial marker) and total ERK (a predominantly cytosolic enzyme). Data are from a single experiment representative of two others First, Bim EL was expressed at low levels in viable cells but was rapidly induced following serum withdrawal. Increased expression of Bim L was also observed, but at much lower levels than Bim EL . Second, Bim EL expression increased in a dose-dependent fashion as cells were switched to progressively lower concentrations of FBS (data not shown). Third, the expression of Bim, like the induction of cell death, was abolished by actinomycin D and cycloheximide. Finally, the transient expression of EGFP-Bim EL was sufficient to kill CC139 cells (Figure 3) .
In addition to CC139 and Rat-1 cells, we have also observed serum withdrawal-induced Bim EL expression in C50 murine keratinocytes (data not shown). Taken together with other studies, these results suggest that increased expression of Bim EL is a common response to withdrawal of survival factors in a variety of cell types including fibroblasts, epithelial cells, lymphocytes and neurons and so may represent a conserved mechanism for promoting apoptosis under these conditions.
While serum withdrawal-induced expression of Bim EL and induction of cell death both exhibit an almost complete requirement for de novo transcription and translation, we cannot rule out the possibility that other BH3-only proteins may be involved in promoting cell death in this system. In certain haematopoietic cells, Bim is the major determinant of factor withdrawalinduced death (Bouillet et al., 1999) , whereas redundant pathways involving Bim and Hrk/DP5 operate in primary sympathetic neurons (Harris and Johnson Jr, 2001; Putcha et al., 2001; Whitfield et al., 2001 ). It is not clear which other BH3-only proteins could be part of a redundant pathway in this system since no candidates exhibit the properties expected from our analysis. For example, removal of serum would be expected to result in dephosphorylation and 'activation' of Bad (Zha et al., 1996; Datta et al., 2000) , but this pathway does not require new gene expression and so is difficult to reconcile with the protective effects of actinomycin D and cycloheximide. Hrk/DP5 is only expressed in neural tissues (Imaizumi et al., 1997) and so is unlikely to be involved in serum withdrawal-induced death in fibroblasts. PUMA and Noxa are transcriptional targets of p53 and are expressed in response to DNA damage (Oda et al., 2000; Nakano and Vousden et al., 2001; Yu et al., 2001) . However, the experimental regimen employed here did not involve DNA damage, and CC139 cells appear to lack functional p53 (Garner et al., 2002) . With these caveats in mind, our results suggest that Bim is involved in initiating apoptosis in response to serum withdrawal in this system.
Bim expression occurs independently of the JNK-c-Jun signalling pathway
Activation of the JNK-c-Jun pathway is required for the expression of Bim and cell death following withdrawal of NGF from primary sympathetic neurons (Estus et al., 1994; Ham et al., 1995; Putcha et al., 2001; Whitfield et al., 2001) . However, our analysis clearly indicates that activation of JNK was neither necessary nor sufficient for Bim expression in CC139 cells, and Bim expression proceeded normally in c-JunÀ/À 3T3 cells compared to WT 3T3 cells. Thus, although expression of Bim appears to be a common response to withdrawal of survival factors in a variety of cells, the signalling pathways that promote this response appear to vary in different cell types. Our results also indicate that Bim expression is not a general response to cellular stress. Although NaAs and MMS both activated the JNK-Jun pathway they failed to induce Bim expression. To date, we have only observed Bim expression in Figure 9 The ERK pathway regulates Bim mRNA levels in Rat-1 cells. (a) RR1 cells, Rat-1 cells expressing DRaf-1:ER* , were switched from complete medium to serum-free medium with or without 4-HT. Whole cell lysates were immunoblotted for Bim, phospho-ERK1/2 and total ERK1/2. (b and c) RR1 cells were switched to serum-free medium or were maintained in complete medium and treated with 20 mm U0126 or 25 mm LY294002. In (b) whole cell lysates were immunoblotted for Bim; total PKB served as a loading control. In (c) total RNA was prepared and used to assay Bim and b-actin transcripts using real-time RT-PCR. Bim transcript levels were normalized to b-actin and data are expressed as fold increase (mean7range of duplicate samples) from a single experiment representative of three giving similar results response to serum withdrawal and not in response to a variety of chemical stresses. It seems that Bim expression is particularly responsive to the withdrawal of survival signals. This is consistent with the notion that higher eukaryotes have evolved a variety of BH3-only genes to allow them to respond to discrete forms of stress (Puthalakath and Strasser, 2002) .
Bim expression is regulated by the ERK pathway independently of the PI3K and JNK pathways In Ba/F3 cells IL-3 represses Bim expression by activating the PI3K-PDK-PKB-FOXO-3A pathway (Dijkers et al., 2000; Shinjyo et al., 2001) . Since PKB phosphorylation decreased upon removal of serum (Figures 1a, 5, 8c) , such a mechanism could account for the induction of Bim EL observed here. Indeed, the PI3K inhibitor LY294002 was sufficient to reduce PKB phosphorylation and promote Bim EL expression even when added to CC139 cells maintained in 10% FBS. However, in the course of these studies we have discovered that the ERK pathway can also regulate Bim expression independently of PI3K. Again, several lines of evidence support this conclusion. First, the MEK-ERK pathway inhibitor, U0126, blocked ERK activation and induced Bim EL expression in cells maintained in 10% FBS. Second, U0126 did not inhibit PKB phosphorylation suggesting that the induction of Bim was not due to inhibition of a potential PI3K-PDK-PKB-FOXO-3A pathway. Third, activation of the ERK pathway by DRaf-1:ER* prevented the increase in Bim EL without promoting PKB phosphorylation. DRaf-1:ER* was also able to inhibit Bim expression following serum withdrawal in Rat-1 cells. Finally, the DRaf-1:ER* block of serum withdrawalinduced Bim expression was reversed by U0126 but not by LY294002.
It is important to stress the PI3K-independent effects of DRaf-1:ER* in this system. DRaf-1:ER* can protect some cells by promoting the expression of HB-EGF, which then acts in an autocrine fashion to activate the PI3K pathway (Schulze et al., 2001 ). We have not observed increases in PKB phosphorylation even after 24 h of DRaf-1:ER* activation in serum-starved CR1-11 cells (data not shown), suggesting that such autocrine loops are not universal. The simplest conclusion from these results is that activation of either the ERK or PI3K pathway is able to inhibit Bim EL expression, and in the case of the ERK pathway this inhibition occurs independently of the PI3K pathway. This is, to our knowledge, the first demonstration that the ERK pathway regulates Bim expression. A previous study in Ba/F3 cells showed that interfering Ras mutants could induce Bim expression but only in concert with wortmannin treatment (Shinjyo et al., 2001) , confirming that PI3K was the major pathway repressing Bim expression in these cells (Dijkers et al., 2000) .
Since U0126 was sufficient to increase Bim mRNA to a similar level as that seen with serum withdrawal in Rat-1 cells, it seems that at least some of the effect of the ERK pathway is to repress Bim transcription, although we cannot rule out the possible regulation of mRNA stability. Whether the ERK pathway also converges on the FOXO transcription factors or regulates a PI3K-independent transcription factor must await analysis of appropriate responsive elements in the Bim promoter. Furthermore, it is notable that LY294002 causes a more pronounced increase in Bim mRNA than U0126 and yet the accumulation of Bim protein was similar for both drugs, raising the possibility that Bim may also be regulated by post-translational means. Indeed, our analysis suggests that Bim is a phospho-protein but the sites of phosphorylation, the kinase responsible and the biochemical consequence remain to be defined.
The ability of DRaf-1:ER* to inhibit serum withdrawal-induced Bim expression is consistent with a model in which at least some of the protective effect of the ERK pathway could be because of the inhibition of Bim expression, thus preserving mitochondrial integrity. Indeed, DRaf-1:ER* can act upstream of the mitochondria by preventing the conformational activation of Bax ( Figure 7c ) and previous studies have shown that DRaf-1:ER* can prevent the release of cytochrome c from mitochondria (Schulze et al., 2001) . However, the ERK pathway may also exert a protective effect downstream of the mitochondria at the level of the apoptosome, preventing the processing of effector caspases (Erhardt et al., 1999) .
In summary, the ERK1/2 pathway can act independently of PI3K to repress Bim expression; indeed, inhibition of either pathway is sufficient to promote Bim expression in the presence of serum. Thus, depending on the cell type, Bim expression can be induced by the activation of JNK or inhibition of ERK or PI3K pathways. Two of these pathways are regulated by Ras proteins (Downward, 1998) , so it will be interesting to examine the expression of Bim in tumour cell lines with known Ras status and in cells with mutational activation of B-Raf (Davies et al., 2002) or the PI3K pathway (Vasquez and Sellars, 2000) . In addition, the human Bim gene maps to chromosome 2q12 or 2q13 and this region is deleted in 10 human tumours, raising the possibility that Bim is a tumour suppressor gene . Thus, tumours may have several mechanisms for reducing Bim expression.
Materials and methods
Materials
Cell culture reagents were purchased from Invitrogen. Superfect transfection reagent was supplied by Qiagen. LY294002 and CPP32 substrate (Ac-DEVD-AMC) were from Calbiochem. U0126 was purchased from Promega. [g-32 P]ATP was purchased from Amersham. The following antibodies were used throughout this study: ERK1, JNK1 and p38a were prepared in house; total c-Jun, phospho-ERK1/2, total ERK1/ 2, total PKB, phospho-PKB (Ser473) and cleaved caspase-3 (17 kDa fragment) were from Cell Signalling Technology/ NEB; Bcl-2 was from Santa Cruz Biotechnology; Bcl-x L was from Pharmingen; Bim was from Chemicon; Bax N-20 was from Calbiochem. Horseradish peroxidase-conjugated secondary antibodies were from Bio-Rad. Unless otherwise stated in the text, all other chemicals were purchased from Sigma.
Cell culture CC139 cells were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 4.5 mg/ml glucose, 100 U/ml penicillin, 100 mg/ml streptomycin, 2 mm glutamine, 10% (v/v) FBS. CR1-11 cells, a stable line of CC139 cells expressing DRaf-1:ER*, and CM1 cells expressing DMEK-K1:ER* (SA Molton, DE Todd, SJ Cook, manuscript in preparation) were produced by transfection with Qiagen Superfect, limiting dilution culture in 6 mg/ml puromycin and ring cloning. All cells expressing DRaf-1:ER* or DMEK-K1:ER* were routinely cultured in phenol red-free medium. For serum starvation, cells judged to be 50-60% confluent were washed once in serum-free medium and then placed in fresh serum-free medium with the indicated dose of 4-HT or the equivalent volume of ethanol (vehicle control) for the times indicated in the figure legends.
Western blotting and subcellular fractionation
At the required times, cells were washed in cold phosphatebuffered saline (PBS) and harvested on ice in TG lysis buffer (20 mm Tris (pH 7.5), 137 mm NaCl, 1 mm EGTA, 1% (v/v) Triton X-100, 10% (v/v) glycerol, 1.5 mm MgCl 2 , 1mm Na 3 VO 4 , 1 mm PMSF, 20 mm leupeptin, 10 mg/ml aprotinin and 50 mm NaF) and processed for Western blotting as described previously (Balmanno and Cook, 1999; Garner et al., 2002) . For subcellular fractionation cells were scraped in 500 ml of ice-cold isotonic fractionation buffer (20 mm HEPES (pH 7.2), 250 mm sucrose, 0.5 mm EDTA, 0.5 mm Na 3 VO 4 , 20 m leupeptin, 10 mg/ml aprotinin and processed by modification of published protocols (Putcha et al., 2001) .
Immunocomplex MAPK/SAPK assays
Following stimulation, cells were lysed and ERK1, JNK1 and p38a were immunoprecipitated and assayed as described previously (Balmanno and Cook, 1999; Garner et al., 2002) .
Analysis of cell cycle profiles and apoptosis
Cells were fixed and stained with propidium iodide as described previously (Garner et al., 2002) . To determine the degree of apoptosis or necrosis, treated cells were trypsinized, washed with PBS and resuspended in binding buffer (10 mm HEPES (pH 7.4), 140 mm NaCl and 2.5 mm CaCl 2 ). Following centrifugation, cells were then stained with a binding buffer containing 0.5 mg/ml annexin V-FITC and 10 mg/ml PI for 15 min at room temperature before being analysed by flow cytometry. DEVDase activity was determined using the synthetic caspase substrate acetyl-Asp-Glu-Val-Asp-7-amino-4-methylcoumarin (Ac-DEVD-AMC). Briefly, cells were harvested on ice in DEVDase lysis buffer (0.5% Nonident P-40, 0.5 mm EDTA, 150 mm NaCl 50 mm Tris (pH 7.5). Cell lysates were snap frozen, thawed on ice and cleared by centrifugation. Cell extract (50 kg) plus 50 mm Ac-DEVD-AMC was made up to a total volume of 200 ml with HEPES buffer (10 mm HEPES (pH 7.5), 50 mm NaCl and 2.5 mm DTT) and incubated at 371C for 1 h. Distilled water (1.8 ml) was added to quench the reaction and sample fluorescence was read using a Perkin-Elmer LS-5 luminescence fluorimeter (excitation 380 nm, emission 460 nm).
Analysis of conformational changes in Bax
Cells (2 Â 10 cm dishes per sample) were left untreated, subjected to serum withdrawal or treated with etoposide as indicated and then lysed in CHAPS lysis buffer (1% CHAPS, 10 mm HEPES (pH 7.4), 150 mm NaCl, 20 mm leupeptin, 10 mg/ ml aprotinin) to preserve the conformation of Bax. Cells lysed in TG lysis buffer, containing 1% Triton X-100, to fully expose the N-20 epitope were used as a positive control. Cell lysates were immunoprecipitated with the N-20 antibody, resolved by SDS-PAGE, transferred to PVDF membranes and probed with Bax antibodies according to published protocols (Marani et al., 2002) .
Real-time RT-PCR
Total mRNA was isolated from RR1 cells using the guanidinium thiocyanate method (Chomczynski and Sacchi, 1987) . Typically, reverse transcription reactions were carried out using 1 mg of RNA and random hexamers in a 20 ml reaction volume following the protocol supplied with the Taqman s Reverse Transcription reagents (Applied Biosystems N808-0234). For rat Bim we used 5 0 -ATCTCAGTG-CAATGGCTTCCA-3 0 as the forward primer and 5 0 -GCTCCTGTGCGATCCGTATC-3 0 as the reverse primer. These primers are common to Bim S , Bim L and Bim EL . For rat b-actin, we used 5 0 -TCGCTGACAGGATGCAGAAAG-3 0 as the forward primer and 5 0 -GGAGCAATGATCTTGATCTT-CATG-3 0 as the reverse primer.
